(B) The serum-starved HepG2 and SK-Hep-1 cell lines were treated with LPS (0, 0.1, 1, or 10 μg/ml) for 24 h. The protein level of TLR4 was determined by western blot analysis. Data are expressed as the mean ± SEM of three independent experiments. *P < 0.05 vs control.
Supplementary Figure 3: (A)
HepG2 and SK-Hep-1 cells was pretreated with sorafenib (1 μM), fluvastatin (1 μM) or both drugs for 24 h. The protein level of p65 in the nucleus was determined by ELISA. *P < 0.05 vs. Con, # P < 0.05 vs. Flu and Δ P < 0.05 vs. Sor. (B) HepG2 and SK-Hep-1 cells were transfected with control vector or TLR4-WT. Twenty-four hours after transfection, HCC cells were pre-treated with DMSO or sorafenib (1 μM) plus fluvastatin (1 μM) for 30 min and then induced with 10 ug/mL LPS for 24 h. Changes in p65 activity were determined by ELISA. Data are expressed as the mean ± SEM of three independent experiments. *P < 0.05 vs. control, # P < 0.05 vs. LPS alone and Δ P < 0.05 vs. LPS+Sor+Flu.
